Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
Breast cancer: A protein to target for double effect A new way to treat some forms of breast cancer might be achieved by drugs that interact with a cell surface protein that binds to growth hormone and transmits growth-inducing signals into the cells. Rajkumar Lakshmanaswamy and colleagues at Texas...
Main Authors: | Arunkumar Arumugam, Ramadevi Subramani, Sushmita Bose Nandy, Daniel Terreros, Alok Kumar Dwivedi, Edward Saltzstein, Rajkumar Lakshmanaswamy |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-01-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-018-0197-8 |
Similar Items
-
Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.
by: Ramadevi Subramani, et al.
Published: (2014-01-01) -
Parity and Short-Term Estradiol Treatment Utilizes Similar Cellular Mechanisms to Confer Protection Against Breast Cancer
by: Arunkumar Arumugam, et al.
Published: (2014-08-01) -
A Breast Tissue Protein Expression Profile Contributing to Early Parity-Induced Protection Against Breast Cancer
by: Christina Marie Gutierrez, et al.
Published: (2015-11-01) -
Classical and Non-Classical Progesterone Signaling in Breast Cancers
by: Diego A. Pedroza, et al.
Published: (2020-08-01) -
Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR.
by: Rebecca Lopez, et al.
Published: (2013-01-01)